PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler School of Medicine, Tel Aviv University, Israel.\', \'School of Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Israel.\', \'Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.\', \'Unit for Cardiovascular Epidemiology, The Gertner Institute for Epidemiology and Health Policy Research, Ramat Gan, Israel.\', \'Leviev Heart Center, Sheba Medical Center, Ramat Gan, Israel.\', \'Azrieli Faculty of Medicine, Bar-Ilan University, Israel.\', \'Department of Oncology, Sheba Medical Center, Tel HaShomer, Israel.\', \'Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/bcp.14546
?:doi
?:hasPublicationType
?:journal
  • British journal of clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 32964535
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.543
?:rankingScore_hIndex
  • 126
is ?:relation_isRelatedTo_publication of
?:title
  • Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32964535>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32964535>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all